• This record comes from PubMed

Biomarkers of nucleic acid oxidation - A summary state-of-the-art

. 2021 Jun ; 42 () : 101872. [epub] 20210128

Language English Country Netherlands Media print-electronic

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Grant support
R01 ES030557 NIEHS NIH HHS - United States
R15 ES027196 NIEHS NIH HHS - United States

Links

PubMed 33579665
PubMed Central PMC8113048
DOI 10.1016/j.redox.2021.101872
PII: S2213-2317(21)00020-3
Knihovny.cz E-resources

Oxidatively generated damage to DNA has been implicated in the pathogenesis of a wide variety of diseases. Increasingly, interest is also focusing upon the effects of damage to the other nucleic acids, RNA and the (2'-deoxy-)ribonucleotide pools, and evidence is growing that these too may have an important role in disease. LC-MS/MS has the ability to provide absolute quantification of specific biomarkers, such as 8-oxo-7,8-dihydro-2'-deoxyGuo (8-oxodG), in both nuclear and mitochondrial DNA, and 8-oxoGuo in RNA. However, significant quantities of tissue are needed, limiting its use in human biomonitoring studies. In contrast, the comet assay requires much less material, and as little as 5 μL of blood may be used, offering a minimally invasive means of assessing oxidative stress in vivo, but this is restricted to nuclear DNA damage only. Urine is an ideal matrix in which to non-invasively study nucleic acid-derived biomarkers of oxidative stress, and considerable progress has been made towards robustly validating these measurements, not least through the efforts of the European Standards Committee on Urinary (DNA) Lesion Analysis. For urine, LC-MS/MS is considered the gold standard approach, and although there have been improvements to the ELISA methodology, this is largely limited to 8-oxodG. Emerging DNA adductomics approaches, which either comprehensively assess the totality of adducts in DNA, or map DNA damage across the nuclear and mitochondrial genomes, offer the potential to considerably advance our understanding of the mechanistic role of oxidatively damaged nucleic acids in disease.

See more in PubMed

Egea J. European contribution to the study of ROS: a summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) Redox Biol. 2017;13:94–162. PubMed PMC

Di Meo S. Role of ROS and RNS Sources in Physiological and pathological conditions. Oxid. Med. Cell longev. 2016;2016:1245049. PubMed PMC

Sies H., Berndt C., Jones D.P. Oxidative stress. Annu. Rev. Biochem. 2017;86:715–748. PubMed

Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biol. 2017;11:613–619. PubMed PMC

Potdar N. First-trimester increase in oxidative stress and risk of small-for-gestational-age fetus. BJOG. 2009;116(5):637–642. PubMed

Birch-Machin M.A., Bowman A. Oxidative stress and ageing. Br. J. Dermatol. 2016;175(Suppl 2):26–29. PubMed

Di Mascio P. Singlet molecular oxygen reactions with nucleic acids, lipids, and proteins. Chem. Rev. 2019;119(3):2043–2086. PubMed

Cooke M.S. Recommendations for standardized description of and nomenclature concerning oxidatively damaged nucleobases in DNA. Chem. Res. Toxicol. 2010;23(4):705–707. PubMed PMC

Cadet J. Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic. Res. 2012;46(4):367–381. PubMed PMC

Evans M.D., Dizdaroglu M., Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 2004;567(1):1–61. PubMed

Cadet J. Formation and repair of oxidatively generated damage in cellular DNA. Free Radic. Biol. Med. 2017;107:13–34. PubMed PMC

Fleming A.M., Burrows C.J. On the irrelevancy of hydroxyl radical to DNA damage from oxidative stress and implications for epigenetics. Chem. Soc. Rev. 2020;49(18):6524–6528. PubMed PMC

Evans M.D., Cooke M.S. Lipid- and Protein-Mediated Oxidative Damage to DNA. In: Singh K.K., editor. Oxidative Stress, Disease and Cancer. Imperial College Press; London: 2006. pp. 201–252.

Moriya M. Single-stranded shuttle phagemid for mutagenesis studies in mammalian cells: 8-oxoguanine in DNA induces targeted G.C-->T.A transversions in simian kidney cells. Proc. Natl. Acad. Sci. U. S. A. 1993;90(3):1122–1126. PubMed PMC

Evans M.D., Cooke M.S. Factors contributing to the outcome of oxidative damage to nucleic acids. Bioessays. 2004;26(5):533–542. PubMed

Kasai H. What causes human cancer? Approaches from the chemistry of DNA damage. Gene Environ. 2016;38:19. PubMed PMC

Cooke M.S. Oxidative DNA damage: mechanisms, mutation, and disease. Faseb. J. 2003;17(10):1195–1214. PubMed

Nelson B.C., Dizdaroglu M. Implications of DNA damage and DNA repair on human diseases. Mutagenesis. 2020;35(1):1–3. PubMed PMC

Moore S.P., Toomire K.J., Strauss P.R. DNA modifications repaired by base excision repair are epigenetic. DNA Repair. 2013;12(12):1152–1158. PubMed

Zarakowska E. Are 8-oxoguanine (8-oxoGua) and 5-hydroxymethyluracil (5-hmUra) oxidatively damaged DNA bases or transcription (Epigenetic) marks? Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2014:764–765. 58–63. PubMed

Olinski R., Starczak M., Gackowski D. Enigmatic 5-hydroxymethyluracil: oxidatively modified base, epigenetic mark or both? Mutat. Res. Rev. Mutat. Res. 2016;767:59–66. PubMed

Allgayer J. Widespread transcriptional gene inactivation initiated by a repair intermediate of 8-oxoguanine. Nucleic Acids Res. 2016;44(15):7267–7280. PubMed PMC

Ba X., Boldogh I. 8-Oxoguanine DNA glycosylase 1: Beyond repair of the oxidatively modified base lesions. Redox Biol. 2018;14:669–678. PubMed PMC

Fleming A.M., Burrows C.J. 8-Oxo-7,8-dihydroguanine, friend and foe: epigenetic-like regulator versus initiator of mutagenesis. DNA Repair. 2017;56:75–83. PubMed PMC

Fleming A.M., Ding Y., Burrows C.J. Oxidative DNA damage is epigenetic by regulating gene transcription via base excision repair. Proc. Natl. Acad. Sci. U. S. A. 2017;114(10):2604–2609. PubMed PMC

Seifermann M., Epe B. Oxidatively generated base modifications in DNA: not only carcinogenic risk factor but also regulatory mark? Free Radic. Biol. Med. 2017;107:258–265. PubMed

Mikhed Y. Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair. Redox Biol. 2015;5:275–289. PubMed PMC

Gorini F. Towards a comprehensive view of 8-oxo-7,8-dihydro-2’-deoxyguanosine: highlighting the intertwined roles of DNA damage and epigenetics in genomic instability. DNA Repair. 2021:97. PubMed PMC

Dziaman T. Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions-benign adenomas and inflammatory bowel disease. Clin. Epigenet. 2018;10:72. PubMed PMC

Olinski R., Gackowski D., Cooke M.S. Endogenously generated DNA nucleobase modifications source, and significance as possible biomarkers of malignant transformation risk, and role in anticancer therapy. Biochim. Biophys. Acta Rev. Canc. 2018;1869(1):29–41. PubMed

Zawia N.H., Lahiri D.K., Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic. Biol. Med. 2009;46(9):1241–1249. PubMed PMC

Coppede F., Migliore L. DNA damage in neurodegenerative diseases. Mutat. Res. 2015;776:84–97. PubMed

Zarakowska E. Oxidation products of 5-methylcytosine are decreased in senescent cells and tissues of progeroid mice. J. Gerontol. A Biol. Sci. Med. Sci. 2018;73(8):1003–1009. PubMed PMC

Ashapkin V.V., Kutueva L.I., Vanyushin B.F. Aging as an epigenetic phenomenon. Curr. Genom. 2017;18(5):385–407. PubMed PMC

Akhmedov A.T., Marin-Garcia J. Mitochondrial DNA maintenance: an appraisal. Mol. Cell. Biochem. 2015;409(1–2):283–305. PubMed

Roubicek D.A., Souza-Pinto N.C. Mitochondria and mitochondrial DNA as relevant targets for environmental contaminants. Toxicology. 2017;391:100–108. PubMed

Zhao L., Sumberaz P. Mitochondrial DNA damage: prevalence, biological consequence, and emerging pathways. Chem. Res. Toxicol. 2020;33(10):2491–2502. PubMed PMC

Gustafson M.A., Sullivan E.D., Copeland W.C. Consequences of compromised mitochondrial genome integrity. DNA Repair. 2020;93:102916. PubMed PMC

Bender A. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 2006;38(5):515–517. PubMed

Arun S., Liu L., Donmez G. Mitochondrial biology and neurological diseases. Curr. Neuropharmacol. 2016;14(2):143–154. PubMed PMC

Kowalska M. Mitochondrial and nuclear DNA oxidative damage in physiological and pathological aging. DNA Cell Biol. 2020;39(8):1410–1420. PubMed

Cencioni C. Oxidative stress and epigenetic regulation in ageing and age-related diseases. Int. J. Mol. Sci. 2013;14(9):17643–17663. PubMed PMC

Minocherhomji S., Tollefsbol T.O., Singh K.K. Mitochondrial regulation of epigenetics and its role in human diseases. Epigenetics. 2012;7(4):326–334. PubMed PMC

Lehle S. LORD-Q: a long-run real-time PCR-based DNA-damage quantification method for nuclear and mitochondrial genome analysis. Nucleic Acids Res. 2014;42(6):p. e41. PubMed PMC

Rooney J.P. PCR based determination of mitochondrial DNA copy number in multiple species. Methods Mol. Biol. 2015;1241:23–38. PubMed PMC

Zhigalina D.I. FISH Diagnostics of chromosomal Translocation with the Technology of Synthesis of locus-specific DNA probes Based on long-range PCR. Russ. J. Genet. 2020;56(6):739–746.

Hanna R. Optimised detection of mitochondrial DNA strand breaks. Mitochondrion. 2019;46:172–178. PubMed

Mansouri A. An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology. 1999;117(1):181–190. PubMed

Alhegaili A.S. Genome-wide adductomics analysis reveals Heterogeneity in the Induction and Loss of cyclobutane thymine Dimers across Both the Nuclear and mitochondrial genomes. Int. J. Mol. Sci. 2019;20(20) PubMed PMC

Wauchope O.R. Oxidative stress increases M1dG, a major peroxidation-derived DNA adduct, in mitochondrial DNA. Nucleic Acids Res. 2018;46(7):3458–3467. PubMed PMC

Rothfuss O., Gasser T., Patenge N. Analysis of differential DNA damage in the mitochondrial genome employing a semi-long run real-time PCR approach. Nucleic Acids Res. 2010;38(4):p. e24. PubMed PMC

Chimienti G. Increased TFAM binding to mtDNA damage hot spots is associated with mtDNA loss in aged rat heart. Free Radic. Biol. Med. 2018;124:447–453. PubMed PMC

Kaniak-Golik A., Skoneczna A. Mitochondria-nucleus network for genome stability. Free Radic. Biol. Med. 2015;82:73–104. PubMed

Saki M., Prakash A. DNA damage related crosstalk between the nucleus and mitochondria. Free Radic. Biol. Med. 2017;107:216–227. PubMed PMC

Kamiya H., Kasai H. Formation of 2-hydroxydeoxyadenosine triphosphate, an oxidatively damaged nucleotide, and its incorporation by DNA polymerases. Steady-state kinetics of the incorporation. J. Biol. Chem. 1995;270(33):19446–19450. PubMed

Bestwick R.K., Moffett G.L., Mathews C.K. Selective expansion of mitochondrial nucleoside triphosphate pools in antimetabolite-treated HeLa cells. J. Biol. Chem. 1982;257(16):9300–9304. PubMed

Mo J.Y., Maki H., Sekiguchi M. Hydrolytic elimination of a mutagenic nucleotide, 8-oxodGTP, by human 18-kilodalton protein: sanitization of nucleotide pool. Proc. Natl. Acad. Sci. U. S. A. 1992;89(22):11021–11025. PubMed PMC

Pursell Z.F. Trace amounts of 8-oxo-dGTP in mitochondrial dNTP pools reduce DNA polymerase gamma replication fidelity. Nucleic Acids Res. 2008;36(7):2174–2181. PubMed PMC

Smith M.R. Molecular and structural characterization of oxidized ribonucleotide insertion into DNA by human DNA polymerase beta. J. Biol. Chem. 2020;295(6):1613–1622. PubMed PMC

Abbas H.H.K. MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells, more bad news than good? BMC Canc. 2018;18(1):423. PubMed PMC

Yoshimura D. An oxidized purine nucleoside triphosphatase, MTH1, suppresses cell death caused by oxidative stress. J. Biol. Chem. 2003;278(39):37965–37973. PubMed

Warpman Berglund U. Validation and development of MTH1 inhibitors for treatment of cancer. Ann. Oncol. 2016;27(12):2275–2283. PubMed

Nakabeppu Y. Cellular levels of 8-oxoguanine in either DNA or the nucleotide pool play pivotal roles in carcinogenesis and survival of cancer cells. Int. J. Mol. Sci. 2014;15(7):12543–12557. PubMed PMC

Rai P. Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence. Oncogene. 2011;30(12):1489–1496. PubMed

McPherson L.A. Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue. DNA Repair. 2019;83:102644. PubMed PMC

Gad H. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature. 2014;508(7495):215–221. PubMed

Rudd S.G. MTH1 inhibitor TH588 disturbs mitotic Progression and induces mitosis-dependent Accumulation of genomic 8-oxodG. Canc. Res. 2020;80(17):3530–3541. PubMed

Huber K.V. Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy. Nature. 2014;508(7495):222–227. PubMed PMC

Ellermann M. Novel class of potent and cellularly active inhibitors devalidates MTH1 as broad-spectrum cancer target. ACS Chem. Biol. 2017;12(8):1986–1992. PubMed

Kettle J.G. Potent and selective inhibitors of MTH1 probe its role in cancer cell survival. J. Med. Chem. 2016;59(6):2346–2361. PubMed

Samaranayake G.J., Huynh M., Rai P. MTH1 as a chemotherapeutic target: the Elephant in the room. Cancers. 2017;9(5) PubMed PMC

Samaranayake G.J. The existence of MTH1-independent 8-oxodGTPase activity in cancer cells as a compensatory mechanism against on-target effects of MTH1 inhibitors. Mol. Canc. Therapeut. 2020;19(2):432–446. PubMed PMC

Nakabeppu Y., Ohta E., Abolhassani N. MTH1 as a nucleotide pool sanitizing enzyme, Friend or foe? Free Radic. Biol. Med. 2017;107:151–158. PubMed

Vitry G. Oxidized DNA precursors Cleanup by NUDT1 Contributes to vascular Remodeling in PAH. Am. J. Respir. Crit. Care Med. 2020 PubMed

Fujikawa K. The oxidized forms of dATP are substrates for the human MutT homologue, the hMTH1 protein. J. Biol. Chem. 1999;274(26):18201–18205. PubMed

Kamiya H., Kasai H. 2-Hydroxyadenine (isoguanine) as oxidative DNA damage: its formation and mutation inducibility. Nucleic Acids Symp. Ser. 1995;(34):233–234. PubMed

Asada S. 2-Oxoadenosine induces cytotoxicity through intracellular accumulation of 2-oxo-ATP and depletion of ATP but not via the p38 MAPK pathway. Sci. Rep. 2017;7(1):6528. PubMed PMC

Jemth A.S. MutT homologue 1 (MTH1) catalyzes the hydrolysis of mutagenic O6-methyl-dGTP. Nucleic Acids Res. 2018;46(20):10888–10904. PubMed PMC

Scaletti E.R. MutT homologue 1 (MTH1) removes N6-methyl-dATP from the dNTP pool. J. Biol. Chem. 2020;295(15):4761–4772. PubMed PMC

Carreras-Puigvert J. A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family. Nat. Commun. 2017;8(1):1541. PubMed PMC

Kong Q., Lin C.L. Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell. Mol. Life Sci. 2010;67(11):1817–1829. PubMed PMC

Hofer T. Hydrogen peroxide causes greater oxidation in cellular RNA than in DNA. Biol. Chem. 2005;386(4):333–337. PubMed

Yan L.L., Zaher H.S. How do cells cope with RNA damage and its consequences? J. Biol. Chem. 2019;294(41):15158–15171. PubMed PMC

Weimann A., Belling D., Poulsen H.E. Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography-electrospray tandem mass spectrometry. Nucleic Acids Res. 2002;30(2):E7. PubMed PMC

Hayakawa H., Kuwano M., Sekiguchi M. Specific binding of 8-oxoguanine-containing RNA to polynucleotide phosphorylase protein. Biochemistry. 2001;40(33):9977–9982. PubMed

Dai D.P. Transcriptional mutagenesis mediated by 8-oxoG induces translational errors in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 2018;115(16):4218–4222. PubMed PMC

Aas P.A. Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature. 2003;421(6925):859–863. PubMed

Bellacosa A., Moss E.G. RNA repair: damage control. Curr. Biol. 2003;13(12):R482–R484. PubMed

Ishii T., Sekiguchi M. Two ways of escaping from oxidative RNA damage: selective degradation and cell death. DNA Repair. 2019;81:102666. PubMed

Kohno K. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays. 2003;25(7):691–698. PubMed

Hayakawa H. Binding capacity of human YB-1 protein for RNA containing 8-oxoguanine. Biochemistry. 2002;41(42):12739–12744. PubMed

Ishii T. PCBP1 and PCBP2 both bind heavily oxidized RNA but cause opposing outcomes, suppressing or increasing apoptosis under oxidative conditions. J. Biol. Chem. 2020;295(34):12247–12261. PubMed PMC

Taddei F. Counteraction by MutT protein of transcriptional errors caused by oxidative damage. Science. 1997;278(5335):128–130. PubMed

Nunomura A. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome. Ann. N. Y. Acad. Sci. 1999;893:362–364. PubMed

Nunomura A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 1999;19(6):1959–1964. PubMed PMC

Kong Q. RNA oxidation: a contributing factor or an epiphenomenon in the process of neurodegeneration. Free Radic. Res. 2008;42(9):773–777. PubMed

Shan X., Tashiro H., Lin C.L. The identification and characterization of oxidized RNAs in Alzheimer's disease. J. Neurosci. 2003;23(12):4913–4921. PubMed PMC

Shan X., Lin C.L. Quantification of oxidized RNAs in Alzheimer's disease. Neurobiol. Aging. 2006;27(5):657–662. PubMed

Chang Y. Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PloS One. 2008;3(8):e2849. PubMed PMC

Shan X., Chang Y., Lin C.L. Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression. Faseb. J. 2007;21(11):2753–2764. PubMed

Gonzalez-Rivera J.C. RNA oxidation in chromatin modification and DNA-damage response following exposure to formaldehyde. Sci. Rep. 2020;10(1):16545. PubMed PMC

Xu Z. Current perspectives on the clinical implications of oxidative RNA damage in aging research: challenges and opportunities. Geroscience. 2020 doi: 10.1007/s11357-020-00209-w. PubMed DOI PMC

Broedbaek K. Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis. Free Radic. Biol. Med. 2009;47(8):1230–1233. PubMed

Broedbaek K. Long-term effects of Irbesartan treatment and smoking on nucleic acid oxidation in patients with type 2 diabetes and microalbuminuria: an Irbesartan in patients with type 2 diabetes and Microalbuminuria (IRMA 2) substudy. Diabetes Care. 2011;34(5):1192–1198. PubMed PMC

Broedbaek K. Urinary markers of nucleic acid oxidation and cancer in type 2 diabetes. Redox Biol. 2015;4:34–39. PubMed PMC

Broedbaek K. Association between urinary markers of nucleic acid oxidation and mortality in type 2 diabetes: a population-based cohort study. Diabetes Care. 2013;36(3):669–676. PubMed PMC

Broedbaek K. Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients. Diabetes Care. 2011;34(12):2594–2596. PubMed PMC

Broedbaek K. Urinary 8-oxo-7,8-dihydro-2’-deoxyguanosine as a biomarker in type 2 diabetes. Free Radic. Biol. Med. 2011;51(8):1473–1479. PubMed

Kjaer L.K. The effect of structured personal care on RNA oxidation: a 19-year follow-up of the randomized trial Diabetes Care in General Practice (DCGP) J. Diabet. Complicat. 2019;33(3):202–207. PubMed

Kjaer L.K. Indicator of RNA oxidation in urine for the prediction of mortality in patients with type 2 diabetes and microalbuminuria: a post-hoc analysis of the Steno-2 trial. Free Radic. Biol. Med. 2018;129:247–255. PubMed

Jorgensen A. Increased systemic oxidatively generated DNA and RNA damage in schizophrenia. Psychiatr. Res. 2013;209(3):417–423. PubMed

Jorgensen A. Systemic oxidatively generated DNA/RNA damage in clinical depression: associations to symptom severity and response to electroconvulsive therapy. J. Affect. Disord. 2013;149(1–3):355–362. PubMed

Munkholm K. A multisystem composite biomarker as a preliminary diagnostic test in bipolar disorder. Acta Psychiatr. Scand. 2019;139(3):227–236. PubMed

Nordholm D. Systemic oxidative DNA and RNA damage are not increased during early phases of psychosis: a case control study. Psychiatr. Res. 2016;241:201–206. PubMed

Xu X.M. Increased oxidative damage of RNA in liver injury caused by hepatitis B virus (HBV) infection. Free Radic. Res. 2018;52(4):426–433. PubMed

Lorente L. Association between DNA and RNA oxidative damage and mortality in septic patients. J. Crit. Care. 2019;54:94–98. doi: 10.1016/j.medin.2019.07.00. PubMed DOI

Lorente L. DNA and RNA oxidative damage are associated to mortality in patients with cerebral infarction. Med. Intensiva. 2019 PubMed

Lorente L. Association between DNA and RNA oxidative damage and mortality of patients with traumatic brain injury. Neurocrit. Care. 2020;32(3):790–795. PubMed

Lorente L. High serum DNA and RNA oxidative damage in non-surviving patients with spontaneous intracerebral hemorrhage. Neurocrit. care. 2020;33(1):90–96. PubMed

Halliwell B., Dizdaroglu M. The measurement of oxidative damage to DNA by HPLC and GC/MS techniques. Free Radic. Res. Commun. 1992;16(2):75–87. PubMed

Floyd R.A. Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation. Free Radic. Res. Commun. 1986;1(3):163–172. PubMed

Dizdaroglu M., Jaruga P., Rodriguez H. Measurement of 8-hydroxy-2’-deoxyguanosine in DNA by high-performance liquid chromatography-mass spectrometry: comparison with measurement by gas chromatography-mass spectrometry. Nucleic Acids Res. 2001;29(3):E12. PubMed PMC

Ravanat J.L. Isotope dilution high-performance liquid chromatography-electrospray tandem mass spectrometry assay for the measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine in biological samples. J. Chromatogr. B Biomed. Sci. Appl. 1998;715(2):349–356. PubMed

Bartsch H., Nair J. Ultrasensitive and specific detection methods for exocylic DNA adducts: markers for lipid peroxidation and oxidative stress. Toxicology. 2000;153(1–3):105–114. PubMed

Cooke M.S. Novel repair action of vitamin C upon in vivo oxidative DNA damage. FEBS Lett. 1998;439(3):363–367. PubMed

Shimoi K. Comparison between high-performance liquid chromatography and enzyme-linked immunosorbent assay for the determination of 8-hydroxy-2’-deoxyguanosine in human urine. Canc. Epidemiol. Biomarkers Prev. 2002;11(8):767–770. PubMed

Pflaum M. DNA oxidation products determined with repair endonucleases in mammalian cells: types, basal levels and influence of cell proliferation. Free Radic. Res. 1998;29(6):585–594. PubMed

Collins A.R. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol. Biotechnol. 2004;26(3):249–261. PubMed

Muller N. An automated Fpg-based FADU method for the detection of oxidative DNA lesions and screening of antioxidants. Toxicology. 2013;310:15–21. PubMed PMC

Gedik C.M., Collins A. Escodd, Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. Faseb. J. 2005;19(1):82–84. PubMed

Escodd Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus. Carcinogenesis. 2002;23(12):2129–2133. PubMed

European Standards Committee on Oxidative Measurement of DNA oxidation in human cells by chromatographic and enzymic methods. Free Radic. Biol. Med. 2003;34(8):1089–1099. PubMed

Lunec J. ESCODD: European standards Committee on oxidative DNA damage. Free Radic. Res. 1998;29(6):601–608. PubMed

Riis B. Comparison of results from different laboratories in measuring 8-oxo-2'-deoxyguanosine in synthetic oligonucleotides. Free Radic. Res. 2002;36(6):649–659. PubMed

Claycamp H.G. Phenol sensitization of DNA to subsequent oxidative damage in 8-hydroxyguanine assays. Carcinogenesis. 1992;13(7):1289–1292. PubMed

Finnegan M.T. Evidence for sensitisation of DNA to oxidative damage during isolation. Free Radic. Biol. Med. 1996;20(1):93–98. PubMed

Guetens G. Oxidative DNA damage: biological significance and methods of analysis. Crit. Rev. Clin. Lab Sci. 2002;39(4–5):331–457. PubMed

Ravanat J.L. Cellular background level of 8-oxo-7,8-dihydro-2'-deoxyguanosine: an isotope based method to evaluate artefactual oxidation of DNA during its extraction and subsequent work-up. Carcinogenesis. 2002;23(11):1911–1918. PubMed

Chao M.R., Yen C.C., Hu C.W. Prevention of artifactual oxidation in determination of cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine by isotope-dilution LC-MS/MS with automated solid-phase extraction. Free Radic. Biol. Med. 2008;44(3):464–473. PubMed

Frelon S. High-performance liquid chromatography–tandem mass spectrometry measurement of radiation-induced base damage to isolated and cellular DNA. Chem. Res. Toxicol. 2000;13(10):1002–1010. PubMed

Cadet J. Assessment of oxidative base damage to isolated and cellular DNA by HPLC-MS/MS measurement. Free Radic. Biol. Med. 2002;33(4):441–449. PubMed

Dizdaroglu M. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic. Biol. Med. 2002;32(11):1102–1115. PubMed

Dizdaroglu M., Coskun E., Jaruga P. Measurement of oxidatively induced DNA damage and its repair, by mass spectrometric techniques. Free Radic. Res. 2015;49(5):525–548. PubMed

Loft S. Antioxidant vitamins and cancer risk: is oxidative damage to DNA a relevant biomarker? Eur. J. Nutr. 2008;47(Suppl 2):19–28. PubMed

Moller P. Applications of the comet assay in particle toxicology: air pollution and engineered nanomaterials exposure. Mutagenesis. 2015;30(1):67–83. PubMed

Moller P. Effect of age and sex on the level of DNA strand breaks and oxidatively damaged DNA in human blood cells. Mutat Res Genet Toxicol Environ Mutagen. 2019;838:16–21. PubMed

Moller P. The comet assay: ready for 30 more years. Mutagenesis. 2018;33(1):1–7. PubMed

Collins A.R. Oxidative damage to DNA: do we have a reliable biomarker? Environ. Health Perspect. 1996;104(Suppl 3):465–469. PubMed PMC

Smith C.C., O'Donovan M.R., Martin E.A. hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII. Mutagenesis. 2006;21(3):185–190. PubMed

Moller P. Assessment and reduction of comet assay variation in relation to DNA damage: studies from the European Comet Assay Validation Group. Mutagenesis. 2010;25(2):109–111. PubMed

Forchhammer L. Variation in the measurement of DNA damage by comet assay measured by the ECVAG inter-laboratory validation trial. Mutagenesis. 2010;25(2):113–123. PubMed

Godschalk R.W. DNA-repair measurements by use of the modified comet assay: an inter-laboratory comparison within the European Comet Assay Validation Group (ECVAG) Mutat. Res. 2013;757(1):60–67. PubMed

Ersson C. An ECVAG inter-laboratory validation study of the comet assay: inter-laboratory and intra-laboratory variations of DNA strand breaks and FPG-sensitive sites in human mononuclear cells. Mutagenesis. 2013;28(3):279–286. PubMed

Forchhammer L. Inter-laboratory variation in DNA damage using a standard comet assay protocol. Mutagenesis. 2012;27(6):665–672. PubMed

Godschalk R.W. Variation of DNA damage levels in peripheral blood mononuclear cells isolated in different laboratories. Mutagenesis. 2014;29(4):241–249. PubMed

Moller P., Loft S. Statistical analysis of comet assay results. Front. Genet. 2014;5:292. PubMed PMC

Moller P. Harmonising measurements of 8-oxo-7,8-dihydro-2'-deoxyguanosine in cellular DNA and urine. Free Radic. Res. 2012;46(4):541–553. PubMed

Ohno M., Oka S., Nakabeppu Y. Quantitative analysis of oxidized guanine, 8-oxoguanine, in mitochondrial DNA by immunofluorescence method. Methods Mol. Biol. 2009;554:199–212. PubMed

Rossner P., Jr., Sram R.J. Immunochemical detection of oxidatively damaged DNA. Free Radic. Res. 2012;46(4):492–522. PubMed

Cooke M.S., Herbert K. Immunochemical detection of 8-oxodeoxyguanosine in DNA. In: Lunec J., Griffiths H.R., editors. Measuring in Vivo Oxidative Damage : A Practical Approach. 2000. pp. 63–68. John Wiley & Sons Ltd: Chichester.

Ohno M. A genome-wide distribution of 8-oxoguanine correlates with the preferred regions for recombination and single nucleotide polymorphism in the human genome. Genome Res. 2006;16(5):567–575. PubMed PMC

Mingard C. Next-generation DNA damage sequencing. Chem. Soc. Rev. 2020;49(20):7354–7377. PubMed

Al-Salmani K. Simplified method for the collection, storage, and comet assay analysis of DNA damage in whole blood. Free Radic. Biol. Med. 2011;51(3):719–725. PubMed

Milic M. Alkaline comet assay results on fresh and one-year frozen whole blood in small volume without cryo-protection in a group of people with different health status. Mutat. Res. 2019;843:3–10. PubMed

Gajski G. Application of the comet assay for the evaluation of DNA damage from frozen human whole blood samples: implications for human biomonitoring. Toxicol. Lett. 2020;319:58–65. PubMed

Ladeira C. The comet assay for human biomonitoring: effect of cryopreservation on DNA damage in different blood cell preparations. Mutat. Res. 2019;843:11–17. PubMed

Hu C.W. 8-Oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2’-deoxyguanosine concentrations in various human body fluids: implications for their measurement and interpretation. Arch. Toxicol. 2015;89(2):201–210. PubMed

Lam P.M. Rapid measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine in human biological matrices using ultra-high-performance liquid chromatography-tandem mass spectrometry. Free Radic. Biol. Med. 2012;52(10):2057–2063. PubMed PMC

Da Broi M.G. Increased concentration of 8-hydroxy-2'-deoxyguanosine in follicular fluid of infertile women with endometriosis. Cell Tissue Res. 2016;366(1):231–242. PubMed

Varnagy A. Levels of total antioxidant capacity and 8-hydroxy-2'-deoxyguanosine of serum and follicular fluid in women undergoing in vitro fertilization: focusing on endometriosis. Hum. Fertil. 2020;23(3):200–208. PubMed

Weimann A., Simonsen A.H., Poulsen H.E. Measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine and 8-oxo-7,8-dihydro-guanosine in cerebrospinal fluid by ultra performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2018;1073:110–117. PubMed

Cooke M.S. Measurement and meaning of oxidatively modified DNA lesions in urine. Canc. Epidemiol. Biomark. Prev. 2008;17(1):3–14. PubMed

Cadet J., Poulsen H. Measurement of oxidatively generated base damage in cellular DNA and urine. Free Radic. Biol. Med. 2010;48(11):1457–1459. PubMed

Pour Khavari A. Serum 8-Oxo-dG as a Predictor of Sensitivity and Outcome of Radiotherapy and Chemotherapy of upper gastrointestinal tumours. Oxid. Med. Cell. Longev. 2018;2018:4153574. PubMed PMC

Ma J. A pilot study of biomarkers of oxidative stress in serum and schizophrenia. Psychiatr. Res. 2020;284:112757. PubMed

Onder C. Impact of non-surgical periodontal therapy on saliva and serum levels of markers of oxidative stress. Clin. Oral Invest. 2017;21(6):1961–1969. PubMed

Ongoz Dede F. The effect of initial periodontal treatment on plasma, gingival crevicular fluid and salivary levels of 8-hydroxy-deoxyguanosine in obesity. Arch. Oral Biol. 2016;62:80–85. PubMed

Dede F.O., Ozden F.O., Avci B. 8-hydroxy-deoxyguanosine levels in gingival crevicular fluid and saliva in patients with chronic periodontitis after initial periodontal treatment. J. Periodontol. 2013;84(6):821–828. PubMed

Takane M. New biomarker evidence of oxidative DNA damage in whole saliva from clinically healthy and periodontally diseased individuals. J. Periodontol. 2002;73(5):551–554. PubMed

Kulkarni N., Cooke M.S., Grigg J. Neutrophils in induced sputum from healthy children: role of interleukin-8 and oxidative stress. Respir. Med. 2007;101(10):2108–2112. PubMed

Cooke M.S. Induction and excretion of ultraviolet-induced 8-oxo-2'-deoxyguanosine and thymine dimers in vivo: implications for PUVA. J. Invest. Dermatol. 2001;116(2):281–285. PubMed

Svecova V. Urinary 8-oxodeoxyguanosine levels in children exposed to air pollutants. Mutat. Res. 2009;662(1–2):37–43. PubMed

Serdar B. Short-term markers of DNA damage among roofers who work with hot asphalt. Environ. Health. 2016;15(1):99. PubMed PMC

Nagao M. Urinary 8-hydroxy-2’-deoxyguanosine Levels and cardiovascular disease Incidence in Japan. J. Atheroscler. Thromb. 2020;27(10):1086–1096. PubMed PMC

Kasai H. A new automated method to analyze urinary 8-hydroxydeoxyguanosine by a high-performance liquid chromatography-electrochemical detector system. J. Radiat. Res. 2003;44(2):185–189. PubMed

Loft S., Poulsen H.E. Markers of oxidative damage to DNA: antioxidants and molecular damage. Methods Enzymol. 1999;300:166–184. PubMed

Cathcart R. Thymine glycol and thymidine glycol in human and rat urine: a possible assay for oxidative DNA damage. Proc. Natl. Acad. Sci. U. S. A. 1984;81(18):5633–5637. PubMed PMC

Bergtold D.S. Urine biomarkers for oxidative DNA damage. Basic Life Sci. 1988;49:483–489. PubMed

Tagesson C. Increased urinary excretion of the oxidative DNA adduct, 8-hydroxydeoxyguanosine, as a possible early indicator of occupational cancer hazards in the asbestos, rubber, and azo-dye industries. Pol. J. Occup. Med. Environ. Health. 1993;6(4):357–368. PubMed

Loft S. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis. 1992;13(12):2241–2247. PubMed

Pilger A. 8-Hydroxydeoxyguanosine in leukocyte DNA and urine of quartz-exposed workers and patients with silicosis. Int. Arch. Occup. Environ. Health. 2000;73(5):305–310. PubMed

Bogdanov M.B. A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods. Free Radic. Biol. Med. 1999;27(5–6):647–666. PubMed

Ravanat J.L. Simultaneous determination of five oxidative DNA lesions in human urine. Chem. Res. Toxicol. 1999;12(9):802–808. PubMed

Rozalski R. Diet is not responsible for the presence of several oxidatively damaged DNA lesions in mouse urine. Free Radic. Res. 2004;38(11):1201–1205. PubMed

Cooke M.S. DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat. Res. 2005;574(1–2):58–66. PubMed

Lin H.S. A high-throughput and sensitive methodology for the quantification of urinary 8-hydroxy-2'-deoxyguanosine: measurement with gas chromatography-mass spectrometry after single solid-phase extraction. Biochem. J. 2004;380(Pt 2):541–548. PubMed PMC

Cooke M.S. Evaluation of enzyme-linked immunosorbent assay and liquid chromatography-tandem mass spectrometry methodology for the analysis of 8-oxo-7,8-dihydro-2'-deoxyguanosine in saliva and urine. Free Radic. Biol. Med. 2006;41(12):1829–1836. PubMed

Evans M.D. Analysis of urinary 8-oxo-7,8-dihydro-purine-2'-deoxyribonucleosides by LC-MS/MS and improved ELISA. Free Radic. Res. 2008;42(10):831–840. PubMed

Hu C.W. Clinical-scale high-throughput analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine by isotope-dilution liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction. Clin. Chem. 2006;52(7):1381–1388. PubMed

Hu C.W. Correlation between concentrations of 8-oxo-7,8-dihydro-2'-deoxyguanosine in urine, plasma and saliva measured by on-line solid-phase extraction LC-MS/MS. Clin. Chim. Acta. 2010;411(17–18):1218–1222. PubMed

Jaruga P., Dizdaroglu M. Identification and quantification of (5'R)- and (5'S)-8,5'-cyclo-2'-deoxyadenosines in human urine as putative biomarkers of oxidatively induced damage to DNA. Biochem. Biophys. Res. Commun. 2010;397(1):48–52. PubMed

Yin B. Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic. Biol. Med. 1995;18(6):1023–1032. PubMed

Toyokuni S. Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab. Invest. 1997;76(3):365–374. PubMed

Rossner P., Jr. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine values determined by a modified ELISA improves agreement with HPLC-MS/MS. Biochem. Biophys. Res. Commun. 2013;440(4):725–730. PubMed

Rossner P., Jr. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine analysis by an improved ELISA: An inter-laboratory comparison study. Free Radic. Biol. Med. 2016;95:169–179. PubMed

European Standards Committee on Urinary Lesion Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a noninvasive biomarker of oxidative stress. Faseb. J. 2010;24(4):1249–1260. PubMed PMC

Barregard L. Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine. Antioxidants Redox Signal. 2013;18(18):2377–2391. PubMed PMC

Haghdoost S. Extracellular 8-oxo-dG as a sensitive parameter for oxidative stress in vivo and in vitro. Free Radic. Res. 2005;39(2):153–162. PubMed

Song M.F. Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG. Free Radic. Biol. Med. 2009;47(1):41–46. PubMed

Chen H.J., Chang C.M. Quantification of urinary excretion of 1,N6-ethenoadenine, a potential biomarker of lipid peroxidation, in humans by stable isotope dilution liquid chromatography-electrospray ionization-tandem mass spectrometry: comparison with gas chromatography-mass spectrometry. Chem. Res. Toxicol. 2004;17(7):963–971. PubMed

Nair J. Etheno DNA-base adducts from endogenous reactive species. Mutat. Res. 1999;424(1–2):59–69. PubMed

Lee K.H. Effect of short-term fasting on urinary excretion of primary lipid peroxidation products and on markers of oxidative DNA damage in healthy women. Carcinogenesis. 2006;27(7):1398–1403. PubMed

Hillestrom P.R. Quantification of 1,N6-etheno-2'-deoxyadenosine in human urine by column-switching LC/APCI-MS/MS. Free Radic. Biol. Med. 2004;36(11):1383–1392. PubMed

Chen H.J. Effect of cigarette smoking on urinary 3,N4-ethenocytosine levels measured by gas chromatography/mass spectrometry. Toxicol. Sci. 2003;76(2):321–327. PubMed

Chen H.J. Urinary excretion of 3,N4-etheno-2'-deoxycytidine in humans as a biomarker of oxidative stress: association with cigarette smoking. Chem. Res. Toxicol. 2004;17(7):896–903. PubMed

Hillestrom P.R., Weimann A., Poulsen H.E. Quantification of urinary etheno-DNA adducts by column-switching LC/APCI-MS/MS. J. Am. Soc. Mass Spectrom. 2006;17(4):605–610. PubMed

Chen H.J., Chiu W.L. Association between cigarette smoking and urinary excretion of 1,N2-ethenoguanine measured by isotope dilution liquid chromatography-electrospray ionization/tandem mass spectrometry. Chem. Res. Toxicol. 2005;18(10):1593–1599. PubMed

Knutson C.G. Monitoring in vivo metabolism and elimination of the endogenous DNA adduct, M1dG {3-(2-deoxy-beta-D-erythro-pentofuranosyl)pyrimido[1,2-alpha]purin-10(3H)-one}, by accelerator mass spectrometry. Chem. Res. Toxicol. 2008;21(6):1290–1294. PubMed PMC

Hoberg A.M. Measurement of the malondialdehyde-2'-deoxyguanosine adduct in human urine by immuno-extraction and liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. J. Mass Spectrom. 2004;39(1):38–42. PubMed

Long L.H., Evans P.J., Halliwell B. Hydrogen peroxide in human urine: implications for antioxidant defense and redox regulation. Biochem. Biophys. Res. Commun. 1999;262(3):605–609. PubMed

Shigenaga M.K., Gimeno C.J., Ames B.N. Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. U. S. A. 1989;86(24):9697–9701. PubMed PMC

Loft S. Oxidative DNA damage after transplantation of the liver and small intestine in pigs. Transplantation. 1995;59(1):16–20. PubMed

Knutson C.G. Metabolism in vitro and in vivo of the DNA base adduct, M1G. Chem. Res. Toxicol. 2007;20(3):550–557. PubMed

Knutson C.G. Metabolism and elimination of the endogenous DNA adduct, 3-(2-deoxy-beta-D-erythropentofuranosyl)-pyrimido[1,2-alpha]purine-10(3H)-one, in the rat. J. Biol. Chem. 2007;282(50):36257–36264. PubMed

Otteneder M.B. In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M1dG. Proc. Natl. Acad. Sci. U. S. A. 2006;103(17):6665–6669. PubMed PMC

Loft S. Prospective study of 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer. Carcinogenesis. 2006;27(6):1245–1250. PubMed

Matsumoto Y. The stability of the oxidative stress marker, urinary 8-hydroxy-2'- deoxyguanosine (8-OHdG), when stored at room temperature. J. Occup. Health. 2008;50(4):366–372. PubMed

Bianchini F. Monitoring urinary excretion of 5-hydroxymethyluracil for assessment of oxidative DNA damage and repair. Biomarkers. 1996;1(3):178–184. PubMed

Hu C.W., Chao M.R., Sie C.H. Urinary analysis of 8-oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanosine by isotope-dilution LC-MS/MS with automated solid-phase extraction: study of 8-oxo-7,8-dihydroguanine stability. Free Radic. Biol. Med. 2010;48(1):89–97. PubMed

Ellegaard P.K., Poulsen H.E. Tobacco smoking and oxidative stress to DNA: a meta-analysis of studies using chromatographic and immunological methods. Scand. J. Clin. Lab. Invest. 2016;76(2):151–158. PubMed

Cooke M.S., Lunec J., Evans M.D. Progress in the analysis of urinary oxidative DNA damage. Free Radic. Biol. Med. 2002;33(12):1601–1614. PubMed

Cooke M.S. A commentary on "Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG". What is ELISA detecting? Free Radic. Biol. Med. 2009;47(1):30–31. PubMed

Guo X. Protective effect of folic acid on oxidative DNA damage: a randomized, double-blind, and placebo controlled clinical trial. Medicine. 2015;94(45):e1872. Baltimore. PubMed PMC

Ambroz A. Impact of air pollution on oxidative DNA damage and lipid peroxidation in mothers and their newborns. Int. J. Hyg Environ. Health. 2016;219(6):545–556. PubMed

Franken C. Phthalate-induced oxidative stress and association with asthma-related airway inflammation in adolescents. Int. J. Hyg Environ. Health. 2017;220(2 Pt B):468–477. PubMed

Wei Y.P. Serum cholesterol positively associated with oxidative DNA damage: a propensity score-matched analysis. Free Radic. Res. 2019;53(4):411–417. PubMed

Poulsen H.E. Detection and interpretation of 8-oxodG and 8-oxoGua in urine, plasma and cerebrospinal fluid. Biochim. Biophys. Acta. 2014;1840(2):801–808. PubMed

Pilger A. Longitudinal study of urinary 8-hydroxy-2'-deoxyguanosine excretion in healthy adults. Free Radic. Res. 2001;35(3):273–280. PubMed

Poulsen H.E. Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. Free Radic. Res. 1998;29(6):565–571. PubMed

Andreoli R. Quantitative determination of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine, 8-oxo-7,8-dihydroguanine, 8-oxo-7,8-dihydroguanosine, and their non-oxidized forms: daily concentration profile in healthy volunteers. Biomarkers. 2010;15(3):221–231. PubMed

Shih Y.M. Clinical relevance of guanine-derived urinary biomarkers of oxidative stress, determined by LC-MS/MS. Redox Biol. 2019;20:556–565. PubMed PMC

Rozalski R. Substantial decrease of urinary 8-oxo-7,8-dihydroguanine, a product of the base excision repair pathway, in DNA glycosylase defective mice. Int. J. Biochem. Cell Biol. 2005;37(6):1331–1336. PubMed

Hayakawa H. Generation and elimination of 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate, a mutagenic substrate for DNA synthesis, in human cells. Biochemistry. 1995;34(1):89–95. PubMed

Hayakawa H. Metabolic fate of oxidized guanine ribonucleotides in mammalian cells. Biochemistry. 1999;38(12):3610–3614. PubMed

Haghdoost S. The nucleotide pool is a significant target for oxidative stress. Free Radic. Biol. Med. 2006;41(4):620–626. PubMed

Arimori T. Diverse substrate recognition and hydrolysis mechanisms of human NUDT5. Nucleic Acids Res. 2011;39(20):8972–8983. PubMed PMC

Cai J.P. Mouse MTH2 protein which prevents mutations caused by 8-oxoguanine nucleotides. Biochem. Biophys. Res. Commun. 2003;305(4):1073–1077. PubMed

Ishibashi T., Hayakawa H., Sekiguchi M. A novel mechanism for preventing mutations caused by oxidation of guanine nucleotides. EMBO Rep. 2003;4(5):479–483. PubMed PMC

Ito R. Cleavage of oxidized guanine nucleotide and ADP sugar by human NUDT5 protein. J. Biochem. 2011;149(6):731–738. PubMed

Carter M. Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2. Nat. Commun. 2015;6:7871. PubMed PMC

Takagi Y. Human MTH3 (NUDT18) protein hydrolyzes oxidized forms of guanosine and deoxyguanosine diphosphates: comparison with MTH1 and MTH2. J. Biol. Chem. 2012;287(25):21541–21549. PubMed PMC

Smith M.R. A guardian residue hinders insertion of a Fapy*dGTP analog by modulating the open-closed DNA polymerase transition. Nucleic Acids Res. 2019;47(6):3197–3207. PubMed PMC

Reardon J.T. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. U. S. A. 1997;94(17):9463–9468. PubMed PMC

Sancar A. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004;73:39–85. PubMed

Cooke M.S. DNA nucleotide excision repair, where do all the cyclobutane pyrimidine dimers go? Cell Cycle. 2013 PubMed PMC

Ahmad J. Urinary thymine dimers and 8-oxo-2'-deoxyguanosine in psoriasis. FEBS Lett. 1999;460(3):549–553. PubMed

Narbutt J. Children sustain high levels of skin DNA photodamage, with a modest increase of serum 25-hydroxyvitamin D3, after a summer holiday in Northern Europe. Br. J. Dermatol. 2018;179(4):940–950. PubMed

Petersen B. Sun and ski holidays improve vitamin D status, but are associated with high levels of DNA damage. J. Invest. Dermatol. 2014;134(11):2806–2813. PubMed

Brooks P.J. The oxidative DNA lesion 8,5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J. Biol. Chem. 2000;275(29):22355–22362. PubMed

Kuraoka I. Removal of oxygen free-radical-induced 5',8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc. Natl. Acad. Sci. U. S. A. 2000;97(8):3832–3837. PubMed PMC

Jaruga P. Evidence for the involvement of DNA repair enzyme NEIL1 in nucleotide excision repair of (5'R)- and (5'S)-8,5'-cyclo-2'-deoxyadenosines. Biochemistry. 2010;49(6):1053–1055. PubMed PMC

Weimann A., Riis B., Poulsen H.E. Oligonucleotides in human urine do not contain 8-oxo-7,8-dihydrodeoxyguanosine. Free Radic. Biol. Med. 2004;36(11):1378–1382. PubMed

Dianov G. Repair pathways for processing of 8-oxoguanine in DNA by mammalian cell extracts. J. Biol. Chem. 1998;273(50):33811–33816. PubMed

Jaiswal M. Efficient in vitro repair of 7-hydro-8-oxodeoxyguanosine by human cell extracts: involvement of multiple pathways. Nucleic Acids Res. 1998;26(9):2184–2191. PubMed PMC

Cappelli E., Degan P., Frosina G. Comparative repair of the endogenous lesions 8-oxo-7, 8-dihydroguanine (8-oxoG), uracil and abasic site by mammalian cell extracts: 8-oxoG is poorly repaired by human cell extracts. Carcinogenesis. 2000;21(6):1135–1141. PubMed

Pascucci B. Reconstitution of the base excision repair pathway for 7,8-dihydro-8-oxoguanine with purified human proteins. Nucleic Acids Res. 2002;30(10):2124–2130. PubMed PMC

Sokhansanj B.A. A quantitative model of human DNA base excision repair. I. Mechanistic insights. Nucleic Acids Res. 2002;30(8):1817–1825. PubMed PMC

Lipinski L.J. Repair of oxidative DNA base lesions induced by fluorescent light is defective in xeroderma pigmentosum group A cells. Nucleic Acids Res. 1999;27(15):3153–3158. PubMed PMC

Klein J.C. Repair and replication of plasmids with site-specific 8-oxodG and 8-AAFdG residues in normal and repair-deficient human cells. Nucleic Acids Res. 1992;20(17):4437–4443. PubMed PMC

Kumar N., Raja S., Van Houten B. The involvement of nucleotide excision repair proteins in the removal of oxidative DNA damage. Nucleic Acids Res. 2020;48(20):11227–11243. PubMed PMC

Evans M.D. Nucleotide excision repair of oxidised genomic DNA is not a source of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine. Free Radic. Biol. Med. 2016;99:385–391. PubMed

Bessho T. Evidence for two DNA repair enzymes for 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) in human cells. J. Biol. Chem. 1993;268(26):19416–19421. PubMed

Cooke M.S. Urinary 8-oxo-2'-deoxyguanosine–source, significance and supplements. Free Radic. Res. 2000;32(5):381–397. PubMed

Lindahl T. Instability and decay of the primary structure of DNA. Nature. 1993;362(6422):709–715. PubMed

Siomek A. Severe oxidatively damaged DNA after cisplatin treatment of cancer patients. Int. J. Canc. 2006;119(9):2228–2230. PubMed

Gackowski D. 8-Oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2’-deoxyguanosine levels in human urine do not depend on diet. Free Radic. Res. 2001;35(6):825–832. PubMed

Fraga C.G. Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. U. S. A. 1990;87(12):4533–4537. PubMed PMC

Chao M.R. Children are particularly vulnerable to environmental tobacco smoke exposure: evidence from biomarkers of tobacco-specific nitrosamines, and oxidative stress. Environ. Int. 2018;120:238–245. PubMed

Barreto M. Urinary and exhaled biomarkers of exercise-induced bronchoconstriction in atopic asthmatic children. Pediatr. Pulmonol. 2019;54(9):1447–1456. PubMed

Li Z. Classification and temporal variability in urinary 8-oxodG and 8-oxoGuo: analysis by UHPLC-MS/MS. Sci. Rep. 2019;9(1):8187. PubMed PMC

Andreoli R. Urinary biomarkers of exposure and of oxidative damage in children exposed to low airborne concentrations of benzene. Environ. Res. 2015;142:264–272. PubMed

Kloppenborg J.T. Urinary markers of nucleic acid oxidation in Danish overweight/obese children and youths. Free Radic. Res. 2016;50(7):691–697. PubMed

Szaflarska-Poplawska A. Oxidatively damaged DNA/oxidative stress in children with celiac disease. Canc. Epidemiol. Biomark. Prev. 2010;19(8):1960–1965. PubMed

Shih B.B. Fractional sunburn threshold UVR doses generate equivalent vitamin D and DNA damage in skin types I-vi but with epidermal DNA damage gradient correlated to skin darkness. J. Invest. Dermatol. 2018;138(10):2244–2252. PubMed PMC

Shih B.B. Influence of skin melanisation and ultraviolet radiation on biomarkers of systemic oxidative stress. Free Radic. Biol. Med. 2020;160:40–46. PubMed PMC

Malic Z. Oxidative stress and genetic variants of xenobiotic-metabolising enzymes associated with COPD development and severity in Serbian adults. COPD. 2017;14(1):95–104. PubMed

Dziaman T. 8-Oxo-7,8-dihydroguanine and uric acid as efficient predictors of survival in colon cancer patients. Int. J. Canc. 2014;134(2):376–383. PubMed

Collins A.R. Oxidative DNA damage measured in human lymphocytes: large differences between sexes and between countries, and correlations with heart disease mortality rates. Faseb. J. 1998;12(13):1397–1400. PubMed

Lenton K.J. Glutathione and ascorbate are negatively correlated with oxidative DNA damage in human lymphocytes. Carcinogenesis. 1999;20(4):607–613. PubMed

Collins A. Launch of the ComNet (comet network) project on the comet assay in human population studies during the International Comet Assay Workshop meeting in Kusadasi, Turkey. Mutagenesis. 2012;27(4):385–386. 13-16. PubMed

Collins A. The comet assay as a tool for human biomonitoring studies: the ComNet project. Mutat. Res. Rev. Mutat. Res. 2014;759:27–39. PubMed

Azqueta A. Technical recommendations to perform the alkaline standard and enzyme-modified comet assay in human biomonitoring studies. Mutat. Res. 2019;843:24–32. PubMed

Azqueta A. DNA repair as a human biomonitoring tool: Comet assay approaches. Mutat. Res. 2019;781:71–87. PubMed

Azqueta A. Application of the comet assay in human biomonitoring: an hCOMET perspective. Mutat. Res. 2020;783:108288. PubMed

Moller P. Minimum Information for Reporting on the Comet Assay (MIRCA): recommendations for describing comet assay procedures and results. Nat. Protoc. 2020;15:3817–3826. PubMed PMC

Moller P. Searching for assay controls for the Fpg- and hOGG1-modified comet assay. Mutagenesis. 2018;33(1):9–19. PubMed

Moller P., Stopper H., Collins A.R. Measurement of DNA damage with the comet assay in high-prevalence diseases: current status and future directions. Mutagenesis. 2020;35(1):5–18. PubMed

Moller P. Potassium bromate as positive assay control for the Fpg-modified comet assay. Mutagenesis. 2020;35(4):341–348. PubMed

Kanaly R.A. Development of the adductome approach to detect DNA damage in humans. Antioxidants Redox Signal. 2006;8(5–6):993–1001. PubMed

Chang Y.J. Novel approach to integrated DNA adductomics for the assessment of in vitro and in vivo environmental exposures. Arch. Toxicol. 2018;92(8):2665–2680. PubMed

Cooke M.S. Urinary DNA adductomics - a novel approach for exposomics. Environ. Int. 2018;121(Pt 2):1033–1038. PubMed PMC

Villalta P.W., Balbo S. The future of DNA adductomic analysis. Int. J. Mol. Sci. 2017;18(9) PubMed PMC

Cao B. Nick-seq for single-nucleotide resolution genomic maps of DNA modifications and damage. Nucleic Acids Res. 2020;48(12):6715–6725. PubMed PMC

Li W., Sancar A. Methodologies for detecting environmentally induced DNA damage and repair. Environ. Mol. Mutagen. 2020;61(7):664–679. PubMed PMC

Payne A. BulkVis: a graphical viewer for Oxford nanopore bulk FAST5 files. Bioinformatics. 2019;35(13):2193–2198. PubMed PMC

An N. Nanopore detection of 8-oxoguanine in the human telomere repeat sequence. ACS Nano. 2015;9(4):4296–4307. PubMed PMC

Alvarez J.R. Mapping base modifications in DNA by transverse-current sequencing. Phys. Rev. Applied. 2018;9 024024.

Ceylan D. Alterations in levels of 8-Oxo-2'-deoxyguanosine and 8-Oxoguanine DNA glycosylase 1 during a current episode and after remission in unipolar and bipolar depression. Psychoneuroendocrinology. 2020;114:104600. PubMed

Jacoby A.S. Increased DNA and RNA damage by oxidation in patients with bipolar I disorder. Transl. Psychiatry. 2016;6(8):e867. PubMed PMC

Mao Y.H. Levels of 8-oxo-dGsn and 8-oxo-Gsn in random urine are consistent with 24 h urine in healthy subjects and patients with renal disease. Free Radic. Res. 2017;51(6):616–621. PubMed

Guo C. Discriminating patients with early-stage breast cancer from benign lesions by detection of oxidative DNA damage biomarker in urine. Oncotarget. 2017;8(32):53100–53109. PubMed PMC

Mao L., Guo C., Zheng S. Elevated urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine and serum uric acid are associated with progression and are prognostic factors of colorectal cancer. OncoTargets Ther. 2018;11:5895–5902. PubMed PMC

Liang Y.D. Urinary 8-oxo-7,8-dihydroguanosine as a potential biomarker of frailty for elderly patients with cardiovascular disease. Free Radic. Biol. Med. 2020;152:248–254. PubMed

Sorensen A.S. The effect of smoking on the urinary excretion of 8-oxodG and 8-oxoGuo in patients with type 2 diabetes. Scand. J. Clin. Lab. Invest. 2017;77(4):253–258. PubMed

Zhao G. A simple method for the determination of 8-oxoguanosine, 8-oxo-2'-deoxyguanosine and 8-iso-prostaglandin F2 alpha. Chromatographia. 2017;80:401–408.

Tranfo G. Levels of urinary biomarkers of oxidatively generated damage to DNA and RNA in different groups of workers compared to general population. Int. J. Environ. Res. Publ. Health. 2019;16(16) PubMed PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...